• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌放射学诊断和治疗反应评估的建议:西班牙医学放射学会和西班牙医学肿瘤学会的国家共识声明。

Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

机构信息

Oncology Department, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain,

出版信息

Clin Transl Oncol. 2015 Jan;17(1):11-23. doi: 10.1007/s12094-014-1231-5. Epub 2014 Nov 6.

DOI:10.1007/s12094-014-1231-5
PMID:25373531
Abstract

The last decade has seen substantial progress in the diagnostic and therapeutic approach to lung cancer, thus meaning that its prognosis has improved. The Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology have therefore produced a national consensus statement to make recommendations for radiological diagnosis and assessment of treatment response in patients with lung cancer. This expert group recommends multi-detector computed tomography as the technique of choice for investigating this disease. The radiology report should include a full assessment by the TNM staging system. Lastly, when the patient is on immunotherapy, response evaluation should employ not only response evaluation criteria in solid tumours, but also immune-related response criteria.

摘要

过去十年中,肺癌的诊断和治疗方法取得了重大进展,因此其预后得到了改善。为此,西班牙医学放射学会和西班牙医学肿瘤学会制定了一份国家共识声明,为肺癌患者的放射诊断和治疗效果评估提出建议。该专家组建议多排螺旋 CT 作为该疾病的首选检查方法。放射学报告应包括采用 TNM 分期系统进行的全面评估。最后,当患者接受免疫治疗时,不仅应使用实体瘤疗效评价标准,还应使用免疫相关疗效评价标准来评估疗效。

相似文献

1
Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.肺癌放射学诊断和治疗反应评估的建议:西班牙医学放射学会和西班牙医学肿瘤学会的国家共识声明。
Clin Transl Oncol. 2015 Jan;17(1):11-23. doi: 10.1007/s12094-014-1231-5. Epub 2014 Nov 6.
2
[Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology].[肺癌的放射学诊断及治疗反应评估建议:西班牙医学放射学会和西班牙医学肿瘤学会的全国共识声明]
Radiologia. 2015 Jan-Feb;57(1):66-78. doi: 10.1016/j.rx.2014.10.002. Epub 2014 Dec 17.
3
SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.SEOM/SERAM关于结直肠癌放射学诊断、疗效评估及随访的共识声明。
Clin Transl Oncol. 2017 Feb;19(2):135-148. doi: 10.1007/s12094-016-1518-9. Epub 2016 May 20.
4
Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.晚期非小细胞肺癌的生物标志物检测:西班牙病理学会和西班牙医学肿瘤学会的全国共识
Clin Transl Oncol. 2015 Feb;17(2):103-12. doi: 10.1007/s12094-014-1248-9. Epub 2014 Oct 29.
5
A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment.免疫治疗治疗反应的形态学和功能学的多学科共识。
Clin Transl Oncol. 2021 Mar;23(3):434-449. doi: 10.1007/s12094-020-02442-3. Epub 2020 Jul 4.
6
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).晚期非小细胞肺癌生物标志物检测指南。西班牙肿瘤医学学会(SEOM)和西班牙病理学会(SEAP)的国家共识。
Clin Transl Oncol. 2012 May;14(5):338-49. doi: 10.1007/s12094-012-0806-2.
7
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.乳腺癌的生物标志物:西班牙肿瘤内科学会和西班牙病理学会的共识声明。
Clin Transl Oncol. 2018 Jul;20(7):815-826. doi: 10.1007/s12094-017-1800-5. Epub 2017 Dec 22.
8
Partnerships in oncology and radiology: the role of radiology in the detection, staging, and follow-up of lung cancer.
Oncologist. 2006 Jul-Aug;11(7):774-9. doi: 10.1634/theoncologist.11-7-774.
9
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.结直肠癌生物标志物检测更新指南:西班牙病理学会和西班牙医学肿瘤学会的全国共识
Clin Transl Oncol. 2015 Apr;17(4):264-73. doi: 10.1007/s12094-014-1252-0. Epub 2014 Nov 6.
10
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).结直肠癌(CRC)生物标志物检测指南:西班牙病理学会(SEAP)和西班牙肿瘤内科学会(SEOM)的国家共识。
Clin Transl Oncol. 2012 Oct;14(10):726-39. doi: 10.1007/s12094-012-0856-5. Epub 2012 Jul 27.

引用本文的文献

1
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.二十年回顾:实体瘤疗效评估标准(RECIST)作为实体瘤反应生物标志物——欧洲癌症研究与治疗组织(EORTC)影像组与欧洲肿瘤内科学会(ESOI)联合论文
Front Oncol. 2022 Jan 10;11:800547. doi: 10.3389/fonc.2021.800547. eCollection 2021.
2
Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions.COBAS表皮生长因子受体半定量指数(SQI)用于EGFR外显子19缺失的非小细胞肺癌患者血浆循环游离DNA检测的技术评估
Diagnostics (Basel). 2021 Jul 22;11(8):1319. doi: 10.3390/diagnostics11081319.
3

本文引用的文献

1
[State of the art and future trends in technology for computed tomography dose reduction].
Radiologia. 2013 Dec;55 Suppl 2:9-16. doi: 10.1016/j.rx.2013.08.004. Epub 2013 Nov 8.
2
Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.不可切除肺癌的全肿瘤 CT 灌注成像用于监测抗血管生成化疗效果。
Br J Radiol. 2013 Sep;86(1029):20120174. doi: 10.1259/bjr.20120174. Epub 2013 Aug 1.
3
Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT.用首过双输入灌注 CT 对良恶性肺结节进行鉴别诊断。
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.
多学科共识声明:关于 III 期非小细胞肺癌患者的临床管理。
Clin Transl Oncol. 2020 Jan;22(1):21-36. doi: 10.1007/s12094-019-02134-7. Epub 2019 Jun 6.
4
Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC).临床和影像学特征推动非小细胞肺癌(NSCLC)患者选择抗血管生成治疗。
Cancer Imaging. 2016 Dec 28;16(1):44. doi: 10.1186/s40644-016-0102-4.
5
Current radiation therapy techniques for lung cancer and its importance for suitable radiological assessment of treatment response in lung cancer.
Clin Transl Oncol. 2015 Jun;17(6):495-6. doi: 10.1007/s12094-015-1286-y. Epub 2015 Apr 8.
Eur Radiol. 2013 Sep;23(9):2469-74. doi: 10.1007/s00330-013-2842-x. Epub 2013 Jun 22.
4
Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.灌注 CT 可预测接受常规和抗血管生成化疗的非小细胞肺癌的治疗反应。
Eur Radiol. 2013 Aug;23(8):2127-36. doi: 10.1007/s00330-013-2821-2. Epub 2013 Apr 4.
5
Assessment of tumor vascularity in lung cancer using volume perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization.使用容积灌注CT(VPCT)评估肺癌肿瘤血管并进行组织病理学比较:迈向个体化肿瘤特征描述的进一步进展。
J Comput Assist Tomogr. 2013 Jan-Feb;37(1):15-21. doi: 10.1097/RCT.0b013e318277c84f.
6
Dual-energy CT of the lung.肺部双能量 CT。
AJR Am J Roentgenol. 2012 Nov;199(5 Suppl):S40-53. doi: 10.2214/AJR.12.9112.
7
Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.利用前瞻性多中心 ACOSOG Z0030 试验数据集重新评估 IB 期非小细胞肺癌中脏层胸膜侵犯的预后价值。
Lung Cancer. 2012 Dec;78(3):259-62. doi: 10.1016/j.lungcan.2012.09.010. Epub 2012 Oct 3.
8
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌(NSCLC):ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. doi: 10.1093/annonc/mds226.
9
[RECIST and the radiologist].[实体瘤疗效评价标准与放射科医生]
Radiologia. 2014 May-Jun;56(3):193-205. doi: 10.1016/j.rx.2012.03.010. Epub 2012 Aug 16.
10
Low-dose CT of the lung: potential value of iterative reconstructions.低剂量 CT 肺部检查:迭代重建的潜在价值。
Eur Radiol. 2012 Dec;22(12):2597-606. doi: 10.1007/s00330-012-2524-0. Epub 2012 Jun 15.